BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10701966)

  • 1. Sedimentation field-flow fractionation application to Toxoplasma gondii separation and purification.
    Bouamrane F; Assidjo NE; Bouteille B; Dreyfuss MF; Dardé ML; Cardot PJ
    J Pharm Biomed Anal; 1999 Jul; 20(3):503-12. PubMed ID: 10701966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast "hyperlayer" separation development in sedimentation field flow fractionation.
    Kassab JR; Cardot PJ; Zahoransky RA; Battu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):8-16. PubMed ID: 16011912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative method for determining Toxoplasma gondii, white cells, and the volume of ascitic fluid in experimentally infected mice.
    Franco EL; de Fatima Duarte E; de Souza AV; Corsini AC
    J Parasitol; 1980 Oct; 66(5):852-3. PubMed ID: 7463258
    [No Abstract]   [Full Text] [Related]  

  • 4. Separation and size distribution of red blood cells of diverse size, shape, and origin by flow/hyperlayer field-flow fractionation.
    Barman BN; Ashwood ER; Giddings JC
    Anal Biochem; 1993 Jul; 212(1):35-42. PubMed ID: 8368513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmolarity effects on red blood cell elution in sedimentation field-flow fractionation.
    Assidjo NE; Chianéa T; Clarot I; Dreyfuss MF; Cardot PJ
    J Chromatogr Sci; 1999 Jul; 37(7):229-36. PubMed ID: 10422264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size separation of supermicrometer particles in asymmetrical flow field-flow fractionation. Flow conditions for rapid elution.
    Wahlund KG; Zattoni A
    Anal Chem; 2002 Nov; 74(21):5621-8. PubMed ID: 12433097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyphenation of sedimentation field flow fractionation with flow cytometry.
    Cardot P; Battu S; Simon A; Delage C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 768(2):285-95. PubMed ID: 11888057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of toxoplasmosis: value of the buffy coat for the detection of circulating Toxoplasma gondii.
    Brenier-Pinchart MP; Capderou E; Bertini RL; Bailly S; Fricker-Hidalgo H; Varlet-Marie E; Murat JB; Sterkers Y; Touafek F; Bastien P; Pelloux H
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):289-91. PubMed ID: 25957458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of purified toxoplasma gondii suspensions.
    Mirovský P; Valkoun A
    Folia Parasitol (Praha); 1981; 28(1):23-7. PubMed ID: 7227866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlayer separation in hollow fiber flow field-flow fractionation: effect of membrane materials on resolution and selectivity.
    Min BR; Kim SJ; Ahn KH; Moon MH
    J Chromatogr A; 2002 Mar; 950(1-2):175-82. PubMed ID: 11990991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of Toxoplasma gondii trophozoites from mouse exudate cells. Comparison of methods.
    Gracheva LI; Masihi KN; Valkoun A; Jíra J
    Folia Parasitol (Praha); 1973; 20(3):203-6. PubMed ID: 4204185
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation of red blood cell fractionation by gravitational field-flow fractionation.
    Urbánková E; Vacek A; Nováková N; Matulík F; Chmelík J
    J Chromatogr; 1992 Nov; 583(1):27-34. PubMed ID: 1484089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of Toxoplasma gondii suspensions from mice peritoneal exudate.
    Robert R; Mauras G; Senet JM; Hocquet P
    Biomed Pharmacother; 1982 Mar; 36(2):98-100. PubMed ID: 7126782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation procedures of sedimentation field-flow fractionation techniques for biological applications.
    Assidjo E; Chianéa T; Dreyfuss MF; Cardot PJ
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):197-207. PubMed ID: 9657216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioseparations.
    Lightfoot EN; Moscariello JS
    Biotechnol Bioeng; 2004 Aug; 87(3):259-73. PubMed ID: 15281101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
    Piergili Fioretti D
    Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.
    Montoya JG
    J Infect Dis; 2002 Feb; 185 Suppl 1():S73-82. PubMed ID: 11865443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii: purification of zoites from peritoneal exudates by eight methods.
    Dempster RP
    Exp Parasitol; 1984 Apr; 57(2):195-207. PubMed ID: 6714360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental toxoplasmosis in mice and rabbits. Virulence and cyst formation of Toxoplasma gondii.
    Pettersen EK
    Acta Pathol Microbiol Scand B; 1977 Feb; 85B(1):95-102. PubMed ID: 842354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of bioseparations: giving credit where credit is due.
    Haynes C
    Biotechnol Bioeng; 2004 Aug; 87(3):257-8. PubMed ID: 15281100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.